Anantaa Gsk Innovations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-11-2024
- Paid Up Capital ₹ 1.00 M
as on 06-11-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 30.40 Cr
as on 06-11-2024
- Revenue 6.06%
(FY 2023)
- Profit 2.95%
(FY 2023)
- Ebitda -181.53%
(FY 2023)
- Net Worth 55.05%
(FY 2023)
- Total Assets 78.70%
(FY 2023)
About Anantaa Gsk Innovations
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹30.40 Cr.
Hemant Sharma, Arti Sharma, and Satinder Vaid serve as directors at the Company.
- CIN/LLPIN
U33110DL2020PTC363752
- Company No.
363752
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 May 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Anantaa Gsk Innovations Private Limited offer?
Anantaa Gsk Innovations Private Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Catheter.
Who are the key members and board of directors at Anantaa Gsk Innovations?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemant Sharma  | Director | 18-May-2020 | Current |
| Arti Sharma | Director | 18-May-2020 | Current |
| Satinder Vaid | Director | 06-Jul-2021 | Current |
Financial Performance of Anantaa Gsk Innovations.
Anantaa Gsk Innovations Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.06% increase. The company also saw a slight improvement in profitability, with a 2.95% increase in profit. The company's net worth Soared by an impressive increase of 55.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anantaa Gsk Innovations?
In 2023, Anantaa Gsk Innovations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Anantaa Gsk Infraconect Private LimitedActive 3 years 29 daysHemant Sharma and Arti Sharma are mutual person
- Anantaa Gsk Itradexpert Private LimitedActive 2 years 10 months
Hemant Sharma and Arti Sharma are mutual person
- Anantaa Gsk Itechnology Private LimitedActive 3 years 5 months
Hemant Sharma and Arti Sharma are mutual person
- Anantaa Gsk Iedusupport Private LimitedActive 3 years 3 days
Hemant Sharma and Arti Sharma are mutual person
- Anantaa Gsk Ifamine Private LimitedActive 1 year 9 months
Hemant Sharma and Arti Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Aug 2023 | ₹4.00 M | Open |
Others Creation Date: 30 May 2022 | ₹30.00 Cr | Open |
How Many Employees Work at Anantaa Gsk Innovations?
Anantaa Gsk Innovations has a workforce of 56 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anantaa Gsk Innovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anantaa Gsk Innovations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
